Stem cell mobilization offers new hope for uterine scarring and infertility
NCT ID NCT05343572
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called plerixafor to see if it can help the body release its own bone marrow stem cells to repair the uterus. It is for women with Asherman's syndrome, a thin uterine lining, or repeated IVF failure. The goal is to thicken the uterine lining and improve pregnancy chances.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASHERMAN SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yale Fertility Center
RECRUITINGOrange, Connecticut, 06477, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could umbilical cord blood help heal the womb?
- Can a traditional chinese herb boost IVF success?
- Could a blood spin help women with failed IVF get pregnant?
- New blood test could boost IVF success for women with repeated failure
- New study probes hidden uterine clues behind repeated miscarriages and IVF failure
- Blood protein may hold key to unexplained miscarriages and IVF failures